瑞典囊性纤维化患者铜绿假单胞菌β-内酰胺耐药分子流行病学与遗传决定因素
该研究对瑞典卡罗林斯卡大学医院囊性纤维化患者中收集的26株铜绿假单胞菌分离株进行全基因组测序和基因组特征分析,旨在阐明其分子流行病学和β-内酰胺耐药的基因组基础。结果显示流行性CF克隆AUST-03(ST242)的传播、多重和广泛耐药菌株的高 prevalence,以及染色体突变(如OprD孔蛋白缺失、ESAC潜在产生、PBP3和AmpC抑制基因突变)驱动β-内酰胺耐药,并发现头孢地尔耐药株存在铁代谢相关基因的功能丧失突变。
要点
- OprD孔蛋白缺失(20/26,77%)导致碳青霉烯耐药。
- 潜在ESAC产生(9/26,35%)与头孢菌素耐药表型一致。
- 头孢地尔耐药CF分离株存在铁代谢相关基因功能丧失突变。
核心结论
- CF相关铜绿假单胞菌耐药负担重,耐药遗传决定因素多样,流行克隆AUST-03在瑞典CF患者中传播。
研究设计与样本
- 对瑞典卡罗林斯卡大学医院CF患者中收集的26株铜绿假单胞菌分离株进行全基因组测序和基因组特征分析。
主要发现
- 鉴定出流行性CF克隆AUST-03(ST242),并观察到多重耐药和广泛耐药菌株高 prevalence。
- 染色体突变驱动β-内酰胺耐药:OprD孔蛋白缺失(20/26,77%)导致碳青霉烯耐药;潜在ESAC产生(9/26,35%)赋予头孢菌素耐药,与表型药敏试验一致。
- 青霉素结合蛋白3和blaAmpC抑制基因突变普遍。
- 头孢地尔耐药CF分离株在部分铁代谢相关基因中存在推定功能丧失突变,而未在头孢地尔敏感分离株中发现,提示其在该耐药中的作用。
临床怎么用
- 这些发现可为CF患者抗菌治疗和感染控制措施提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pseudomonas aeruginosa (PA), an opportunistic Gram-negative pathogen, is a leading cause of severe pulmonary infections in individuals with cystic fibrosis (CF). A significant proportion of patients become chronically infected, with negative consequences on respiratory function. Repeated or long-time suppressive antimicrobial treatment is often necessary, promoting development of antimicrobial resistance. Certain clones are particularly successful because of enhanced transmissibility and resistance development. We aimed to characterize the molecular epidemiology and genomic basis of β-lactam resistance in PA isolates from patients with CF in Sweden. METHODS: We performed whole genome sequencing and genomic characterization of 26 PA isolates collected from patients with CF at Karolinska University Hospital, Sweden. RESULTS: We identified the epidemic CF clone AUST-03 (ST242) and observed a high prevalence of multidrug- and extensively drug-resistant strains. Chromosomal mutations drove β-lactam resistance, with OprD porin loss (20 of 26, 77%) causing carbapenem resistance and potential production of extended-spectrum AmpC (9 of 26, 35%) conferring cephalosporin resistance, aligned with phenotypic susceptibility testing. Mutations in penicillin-binding protein 3 and blaAmpC repressors were prevalent. Notably, cefiderocol-resistant CF isolates had putative loss-of-function mutations in some iron metabolism-associated genes not found in cefiderocol-susceptible isolates, suggesting their role in resistance. CONCLUSIONS: The results highlight the burden of antimicrobial resistance in CF-associated PA, distinct genetic determinants of resistance and the spread of epidemic clone AUST-03 in Swedish patients with CF. These insights can inform antimicrobial therapy and infection control measures.
引用
- Loo E, Tellapragada C, Razavi M, et al. Molecular epidemiology and genetic determinants of β-lactam resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Stockholm, Sweden. Clin Microbiol Infect. 2026. PMID: 41956396. doi:10.1016/j.cmi.2026.03.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。